IJR.AX - iShares S&P Small-Cap ETF

ASX - ASX Delayed Price. Currency in AUD
109.20
-1.78 (-1.60%)
At close: 3:48PM AEST
Stock chart is not supported by your current browser
Previous Close110.98
Open110.00
BidN/A x N/A
AskN/A x N/A
Day's Range108.54 - 110.00
52 Week Range94.42 - 127.50
Volume3,299
Avg. VolumeN/A
Net AssetsN/A
NAVN/A
PE Ratio (TTM)N/A
YieldN/A
YTD ReturnN/A
Beta (3Y Monthly)N/A
Expense Ratio (net)N/A
Inception DateN/A
  • Aveo Pharmaceuticals Stock Fell More than 60% on January 31
    Market Realist4 months ago

    Aveo Pharmaceuticals Stock Fell More than 60% on January 31

    Aveo Pharmaceuticals Stock Fell More than 60% on January 31Share price movementsOn January 31, Aveo Pharmaceuticals (AVEO) issued a press release announcing its decision not to file an NDA (new drug application) for its drug, Fotivda (tivozanib),

  • Why iRobot Stock Has Surged ~5% Today
    Market Realist4 months ago

    Why iRobot Stock Has Surged ~5% Today

    Why iRobot Stock Has Surged ~5% TodayiRobot stockToday, iRobot (IRBT) stock surged 5.3% before the market opened. At 9:50 AM Eastern Time, it was up 3.7%, while the S&P 500 and the NASDAQ Composite had risen 0.5% and 0.8%, respectively.

  • A Financial Overview of Supernus Pharmaceuticals in September
    Market Realist8 months ago

    A Financial Overview of Supernus Pharmaceuticals in September

    In the second quarter, Supernus Pharmaceuticals (SUPN) reported net revenues of $99.5 million compared to $75.8 million in the second quarter of 2017. In the first half, Supernus Pharmaceuticals generated net revenues of $190.0 million compared to $133.4 million in the first half of 2017.